p
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
(Mark One)
|
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For The Quarterly Period Ended March 31, 2018
OR
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission File Number: 814-00702
HERCULES CAPITAL, INC.
(Exact Name of Registrant as Specified in its Charter)
|
Maryland |
|
743113410 |
|
(State or Jurisdiction of Incorporation or Organization) |
|
(IRS Employer Identification No.) |
|
400 Hamilton Ave., Suite 310 Palo Alto, California (Address of Principal Executive Offices) |
|
94301 (Zip Code) |
|
|
(650) 289-3060
(Registrant’s Telephone Number, Including Area Code)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this Chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☐ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer |
|
☒ |
|
Accelerated filer |
|
☐ |
|
|
|
|
|
|||
|
Non-accelerated filer |
|
☐ |
|
Smaller reporting company |
|
☐ |
|
Emerging growth company |
|
☐ |
|
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with a new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. |
|
☐ |
||||
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
On April 30, 2018, there were 85,899,098 shares outstanding of the Registrant’s common stock, $0.001 par value.
FORM 10-Q TABLE OF CONTENTS
|
|
3 |
|||
|
Item 1. |
|
|
|
3 |
|
|
|
|
|
3 |
|
|
|
Consolidated Statement of Operations for the three months ended March 31, 2018 and 2017 (unaudited) |
|
5 |
|
|
|
|
|
6 |
|
|
|
Consolidated Statement of Cash Flows for the three months ended March 31, 2018 and 2017 (unaudited) |
|
7 |
|
|
|
Consolidated Schedule of Investments as of March 31, 2018 (unaudited) |
|
9 |
|
|
|
Consolidated Schedule of Investments as of December 31, 2017 (unaudited) |
|
24 |
|
|
|
|
|
39 |
|
Item 2. |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|
71 |
|
Item 3. |
|
|
|
89 |
|
Item 4. |
|
|
|
90 |
|
|
|
91 |
||
|
Item 1. |
|
|
91 |
|
|
Item 1A. |
|
|
|
91 |
|
Item 2. |
|
|
|
92 |
|
Item 3. |
|
|
92 |
|
|
Item 4. |
|
|
|
92 |
|
Item 5. |
|
|
|
92 |
|
Item 6. |
|
|
|
94 |
|
|
|
97 |
||
2
In this Quarterly Report, the “Company,” “Hercules,” “we,” “us” and “our” refer to Hercules Capital, Inc. and its wholly owned subsidiaries and its affiliated securitization trusts on or after February 25, 2016 and “Hercules Technology Growth Capital, Inc.” and its wholly owned subsidiaries and its affiliated securitization trusts prior to February 25, 2016, unless the context otherwise requires.
HERCULES CAPITAL, INC.
CONSOLIDATED STATEMENT OF ASSETS AND LIABILITIES
(unaudited)
(dollars in thousands, except per share data)
|
|
|
March 31, 2018 |
|
|
December 31, 2017 |
|
||
|
Assets |
|
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
|
Non-control/Non-affiliate investments (cost of $1,427,863 and $1,506,454, respectively) |
|
$ |
1,398,640 |
|
|
$ |
1,491,458 |
|
|
Control investments (cost of $60,992 and $25,419, respectively) |
|
|
54,413 |
|
|
|
19,461 |
|
|
Affiliate investments (cost of $87,423 and $87,956, respectively) |
|
|
30,525 |
|
|
|
31,295 |
|
|
Total investments in securities, at value (cost of $1,576,278 and $1,619,829, respectively) |
|
|
1,483,578 |
|
|
|
1,542,214 |
|
|
Cash and cash equivalents |
|
|
118,228 |
|
|
|
91,309 |
|
|
Restricted cash |
|
|
3,632 |
|
|
|
3,686 |
|
|
Interest receivable |
|
|
11,087 |
|
|
|
12,262 |
|
|
Other assets |
|
|
3,187 |
|
|
|
5,244 |
|
|
Total assets |
|
$ |
1,619,712 |
|
|
$ |
1,654,715 |
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities |
|
$ |
18,789 |
|
|
$ |
26,896 |
|
|
SBA Debentures, net (principal of $190,200 and $190,200, respectively) (1) |
|
|
188,299 |
|
|
|
188,141 |
|
|
2022 Notes, net (principal of $150,000 and $150,000, respectively) (1) |
|
|
147,698 |
|
|
|
147,572 |
|
|
2024 Notes, net (principal of $183,510 and $183,510, respectively) (1) |
|
|
179,161 |
|
|
|
179,001 |
|
|
2021 Asset-Backed Notes, net (principal of $33,575 and $49,153, respectively) (1) |
|
|
33,156 |
|
|
|
48,650 |
|
|
2022 Convertible Notes, net (principal of $230,000 and $230,000, respectively) (1) |
|
|
223,878 |
|
|
|
223,488 |
|
|
Total liabilities |
|
$ |
790,981 |
|
|
$ |
813,748 |
|
|
|
|
|
|
|
|
|
|
|
|
Net assets consist of: |
|
|
|
|
|
|
|
|
|
Common stock, par value |
|
|
85 |
|
|
|
85 |
|
|
Capital in excess of par value |
|
|
916,738 |
|
|
|
908,501 |
|
|
Unrealized depreciation on investments (2) |
|
|
(94,957 |
) |
|
|
(79,760 |
) |
|
Accumulated undistributed realized gains (losses) on investments |
|
|
(25,294 |
) |
|
|
(20,374 |
) |
|
Undistributed net investment income |
|
|
32,159 |
|
|
|
32,515 |
|
|
Total net assets |
|
$ |
828,731 |
|
|
$ |
840,967 |
|
|
Total liabilities and net assets |
|
$ |
1,619,712 |
|
|
$ |
1,654,715 |
|
|
|
|
|
|
|
|
|
|
|
|
Shares of common stock outstanding ($0.001 par value, 200,000,000 authorized) |
|
|
85,239 |
|
|
|
84,424 |
|
|
Net asset value per share |
|
$ |
9.72 |
|
|
$ |
9.96 |
|
|
(1) |
The Company’s SBA Debentures, 2022 Notes, 2024 Notes, 2021 Asset-Backed Notes and 2022 Convertible Notes, as each term is defined herein, are presented net of the associated debt issuance costs for each instrument. See “Note 4 – Borrowings”. |
|
(2) |
Amounts include $2.3 million and $2.1 million in net unrealized depreciation on other assets and accrued liabilities, including escrow receivables, and estimated taxes payable as of March 31, 2018 and December 31, 2017, respectively. |
See notes to consolidated financial statements.
3
The following table presents the assets and liabilities of our consolidated securitization trust for the 2021 Asset-Backed Notes (see Note 4), which is a variable interest entity (“VIE”). The assets of our securitization VIE can only be used to settle obligations of our consolidated securitization VIE, these liabilities are only the obligations of our consolidated securitization VIE, and the creditors (or beneficial interest holders) do not have recourse to our general credit. These assets and liabilities are included in the Consolidated Statement of Assets and Liabilities above.
|
(Dollars in thousands) |
|
March 31, 2018 |
|
|
December 31, 2017 |
|
||
|
Assets |
|
|
|
|
|
|
|
|
|
Restricted Cash |
|
$ |
3,632 |
|
|
$ |
3,686 |
|
|
Total investments in securities, at value (cost of $117,441 and $146,208, respectively) |
|
|
112,826 |
|
|
|
144,513 |
|
|
Total assets |
|
$ |
116,458 |
|
|
$ |
148,199 |
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
2021 Asset-Backed Notes, net (principal of $33,575 and $49,153, respectively) (1) |
|
$ |
33,156 |
|
|
$ |
48,650 |
|
|
Total liabilities |
|
$ |
33,156 |
|
|
$ |
48,650 |
|
|
(1) |
The Company’s 2021 Asset-Backed Notes are presented net of the associated debt issuance costs. See “Note 4 – Borrowings”. |
See notes to consolidated financial statements.
4
CONSOLIDATED STATEMENT OF OPERATIONS
(unaudited)
(in thousands, except per share data)
|
|
Three Months Ended March 31, |
|
|||||
|
|
2018 |
|
|
2017 |
|
||
|
Investment income: |
|
|
|
|
|
|
|
|
Interest income |
|
|
|
|
|
|
|
|
Non-control/Non-affiliate investments |
$ |
41,834 |
|
|
$ |
42,345 |
|
|
Control investments |
|
586 |
|
|
|
514 |
|
|
Affiliate investments |
|
561 |
|
|
|
2 |
|
|
Total interest income |
|
42,981 |
|
|
|
42,861 |
|
|
Fee income |
|
|
|
|
|
|
|
|
Commitment, facility and loan fee income: |
|
|
|
|
|
|
|
|
Non-control/Non-affiliate investments |
|
2,440 |
|
|
|
2,934 |
|
|
Control investments |
|
— |
|
|
|
5 |
|
|
Affiliate investments |
|
108 |
|
|
|
— |
|
|
Total commitment, facility and loan fee income |
|
2,548 |
|
|
|
2,939 |
|
|
One-time fee income: |
|
|
|
|
|
|
|
|
Non-control/Non-affiliate investments |
|
3,171 |
|
|
|
565 |
|
|
Total one-time fee income |
|
3,171 |
|
|
|
565 |
|
|
Total fee income |
|
5,719 |
|
|
|
3,504 |
|
|
Total investment income |
|
48,700 |
|
|
|
46,365 |
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
Interest |
|
9,386 |
|
|
|
9,607 |
|
|
Loan fees |
|
1,175 |
|
|
|
2,838 |
|
|
General and administrative |
|
4,009 |
|
|
|
4,064 |
|
|
Employee compensation: |
|
|
|
|
|
|
|
|
Compensation and benefits |
|
5,758 |
|
|
|
5,345 |
|
|
Stock-based compensation |
|
2,309 |
|
|
|
1,833 |
|
|
Total employee compensation |
|
8,067 |
|
|
|
7,178 |
|
|
Total operating expenses |
|
22,637 |
|
|
|
23,687 |
|
|
Net investment income |
|
26,063 |
|
|
|
22,678 |
|
|
Net realized gain (loss) on investments |
|
|
|
|
|
|
|
|
Non-control/Non-affiliate investments |
|
(3,512 |
) |
|
|
3,288 |
|
|
Control investments |
|
(1,408 |
) |
|
|
(51 |
) |
|
Total net realized gain (loss) on investments |
|
(4,920 |
) |
|
|
3,237 |
|
|
Net change in unrealized appreciation (depreciation) on investments |
|
|
|
|
|
|
|
|
Non-control/Non-affiliate investments |
|
(14,340 |
) |
|
|
(32,155 |
) |
|
Control investments |
|
(620 |
) |
|
|
213 |
|
|
Affiliate investments |
|
(237 |
) |
|
|
439 |
|
|
Total net unrealized appreciation (depreciation) on investments |
|
(15,197 |
) |
|
|
(31,503 |
) |
|
Total net realized and unrealized gain (loss) |
|
(20,117 |
) |
|
|
(28,266 |
) |
|
Net increase (decrease) in net assets resulting from operations |
$ |
5,946 |
|
|
$ |
(5,588 |
) |
|
|
|
|
|
|
|
|
|
|
Net investment income before investment gains and losses per common share: |
|
|
|
|
|
|
|
|
Basic |
$ |
0.31 |
|
|
$ |
0.28 |
|
|
Change in net assets resulting from operations per common share: |
|
|
|
|
|
|
|
|
Basic |
$ |
0.07 |
|
|
$ |
(0.07 |
) |
|
Diluted |
$ |
0.07 |
|
|
$ |
(0.07 |
) |
|
Weighted average shares outstanding |
|
|
|
|
|
|
|
|
Basic |
|
84,596 |
|
|
|
81,420 |
|
|
Diluted |
|
84,666 |
|
|
|
81,420 |
|
|
Distributions declared per common share: |
|
|
|
|
|
|
|
|
Basic |
$ |
0.31 |
|
|
$ |
0.31 |
|
See notes to consolidated financial statements.
5
CONSOLIDATED STATEMENT OF CHANGES IN NET ASSETS
(unaudited)
(dollars and shares in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
Undistributed |
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
Capital in |
|
|
Appreciation |
|
|
Realized |
|
|
Undistributed |
|
|
|
|
|
||||
|
|
Common Stock |
|
|
excess |
|
|
(Depreciation) |
|
|
Gains (Losses) |
|
|
Net Investment |
|
|
Net |
|
||||||||||
|
|
Shares |
|
|
Par Value |
|
|
of par value |
|
|
on Investments |
|
|
on Investments |
|
|
Income |
|
|
Assets |
|
|||||||
|
Balance at December 31, 2016 |
|
79,555 |
|
|
$ |
80 |
|
|
$ |
839,657 |
|
|
$ |
(89,025 |
) |
|
$ |
14,314 |
|
|
$ |
22,918 |
|
|
$ |
787,944 |
|
|
Net increase (decrease) in net assets resulting from operations |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(31,503 |
) |
|
|
3,237 |
|
|
|
22,678 |
|
|
|
(5,588 |
) |
|
Public offering, net of offering expenses |
|
3,309 |
|
|
|
3 |
|
|
|
46,945 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
46,948 |
|
|
Issuance of common stock due to stock option exercises |
|
24 |
|
|
|
— |
|
|
|
181 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
181 |
|
|
Retired shares from net issuance |
|
(16 |
) |
|
|
— |
|
|
|
(140 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(140 |
) |
|
Issuance of common stock under restricted stock plan |
|
4 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Retired shares for restricted stock vesting |
|
(101 |
) |
|
|
— |
|
|
|
(1,433 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,433 |
) |
|
Distributions reinvested in common stock |
|
26 |
|
|
|
— |
|
|
|
388 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
388 |
|
|
Issuance of Convertible Notes |
|
— |
|
|
|
— |
|
|
|
3,413 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,413 |
|
|
Distributions |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(25,667 |
) |
|
|
(25,667 |
) |
|
Stock-based compensation (1) |
|
— |
|
|
|
— |
|
|
|
1,850 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,850 |
|
|
Balance at March 31, 2017 |
|
82,801 |
|
|
$ |
83 |
|
|
$ |
890,861 |
|
|
$ |
(120,528 |
) |
|
$ |
17,551 |
|
|
$ |
19,929 |
|
|
$ |
807,896 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2017 |
|
84,424 |
|
|
$ |
85 |
|
|
$ |
908,501 |
|
|
$ |
(79,760 |
) |
|
$ |
(20,374 |
) |
|
$ |
32,515 |
|
|
$ |
840,967 |
|
|
Net increase (decrease) in net assets resulting from operations |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(15,197 |
) |
|
|
(4,920 |
) |
|
|
26,063 |
|
|
|
5,946 |
|
|
Public offering, net of offering expenses |
|
478 |
|
|
|
— |
|
|
|
5,952 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
5,952 |
|
|
Issuance of common stock due to stock option exercises |
|
38 |
|
|
|
— |
|
|
|
432 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
432 |
|
|
Retired shares from net issuance |
|
(36 |
) |
|
|
— |
|
|
|
(446 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(446 |
) |
|
Issuance of common stock under restricted stock plan |
|
336 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Retired shares for restricted stock vesting |
|
(36 |
) |
|
|
— |
|
|
|
(446 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(446 |
) |
|
Distributions reinvested in common stock |
|
35 |
|
|
|
— |
|
|
|
426 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
426 |
|
|
Distributions |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(26,419 |
) |
|
|
(26,419 |
) |
|
Stock-based compensation (1) |
|
— |
|
|
|
— |
|
|
|
2,319 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,319 |
|
|
Balance at March 31, 2018 |
|
85,239 |
|
|
$ |
85 |
|
|
$ |
916,738 |
|
|
$ |
(94,957 |
) |
|
$ |
(25,294 |
) |
|
$ |
32,159 |
|
|
$ |
828,731 |
|
|
(1) |
Stock-based compensation includes $10 and $17 of restricted stock and option expense related to director compensation for the three months ended March 31, 2018 and 2017, respectively. |
See notes to consolidated financial statements.
6
CONSOLIDATED STATEMENT OF CASH FLOWS
(unaudited)
(dollars in thousands)
|
|
For the Three Months Ended March 31, |
|
|||||
|
|
2018 |
|
|
2017 |
|
||
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net increase (decrease) in net assets resulting from operations |
$ |
5,946 |
|
|
$ |
(5,588 |
) |
|
Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by (used in) operating activities: |
|
|
|
|
|
|
|
|
Purchase of investments |
|
(236,285 |
) |
|
|
(153,665 |
) |
|
Principal and fee payments received on investments |
|
280,181 |
|
|
|
141,798 |
|
|
Proceeds from the sale of investments |
|
1,582 |
|
|
|
11,995 |
|
|
Net unrealized depreciation (appreciation) on investments |
|
15,197 |
|
|
|
31,503 |
|
|
Net realized loss (gain) on investments |
|
4,920 |
|
|
|
(3,237 |
) |
|
Accretion of paid-in-kind principal |
|
(2,507 |
) |
|
|
(2,199 |
) |
|
Accretion of loan discounts |
|
(763 |
) |
|
|
(1,924 |
) |
|
Accretion of loan discount on Convertible Notes |
|
168 |
|
|
|
112 |
|
|
Accretion of loan exit fees |
|
(4,407 |
) |
|
|
(6,574 |
) |
|
Change in deferred loan origination revenue |
|
631 |
|
|
|
284 |
|
|
Unearned fees related to unfunded commitments |
|
321 |
|
|
|
976 |
|
|
Amortization of debt fees and issuance costs |
|
840 |
|
|
|
2,508 |
|
|
Depreciation |
|
46 |
|
|
|
52 |
|
|
Stock-based compensation and amortization of restricted stock grants (1) |
|
2,319 |
|
|
|
1,850 |
|
|
Change in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Interest and fees receivable |
|
1,175 |
|
|
|
130 |
|
|
Prepaid expenses and other assets |
|
1,870 |
|
|
|
(1,061 |
) |
|
Accounts payable |
|
(194 |
) |
|
|
1 |
|
|
Accrued liabilities |
|
(8,025 |
) |
|
|
(5,255 |
) |
|
Net cash provided by (used in) operating activities |
|
63,015 |
|
|
|
11,706 |
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Purchases of capital equipment |
|
(72 |
) |
|
|
(39 |
) |
|
Net cash provided by (used in) investing activities |
|
(72 |
) |
|
|
(39 |
) |
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Issuance of common stock, net |
|
5,952 |
|
|
|
46,948 |
|
|
Retirement of employee shares |
|
(460 |
) |
|
|
(1,392 |
) |
|
Distributions paid |
|
(25,993 |
) |
|
|
(25,279 |
) |
|
Issuance of 2022 Convertible Notes |
|
— |
|
|
|
230,000 |
|
|
Issuance of 2024 Notes |
|
— |
|
|
|
5,637 |
|
|
Repayments of 2019 Notes |
|
— |
|
|
|
(110,365 |
) |
|
Repayments of 2021 Asset-Backed Notes |
|
(15,577 |
) |
|
|
(7,794 |
) |
|
Borrowings of credit facilities |
|
— |
|
|
|
8,497 |
|
|
Repayments of credit facilities |
|
— |
|
|
|
(13,513 |
) |
|
Cash paid for debt issuance costs |
|
— |
|
|
|
(4,456 |
) |
|
Fees paid for credit facilities and debentures |
|
— |
|
|
|
(252 |
) |
|
Net cash provided by (used in) financing activities |
|
(36,078 |
) |
|
|
128,031 |
|
|
Net increase (decrease) in cash, cash equivalents and restricted cash |
|
26,865 |
|
|
|
139,698 |
|
|
Cash, cash equivalents and restricted cash at beginning of period |
|
94,995 |
|
|
|
21,366 |
|
|
Cash, cash equivalents and restricted cash at end of period |
$ |
121,860 |
|
|
$ |
161,064 |
|
|
|
|
|
|
|
|
|
|
|
Supplemental non-cash investing and financing activities: |
|
|
|
|
|
|
|
|
Distributions reinvested |
|
426 |
|
|
|
388 |
|
|
(1) |
Stock-based compensation includes $10 and $17 of restricted stock and option expense related to director compensation for the three months ended March 31, 2018 and 2017, respectively. |
See notes to consolidated financial statements.
7
The following table presents a reconciliation of cash, cash equivalents and restricted cash reported within the Consolidated Statement of Assets and Liabilities that sum to the total of the same such amounts in the Consolidated Statement of Cash Flows:
|
|
For the Three Months Ended March 31, |
|
|||||
|
(Dollars in thousands) |
2018 |
|
|
2017 |
|
||
|
Cash and cash equivalents |
$ |
118,228 |
|
|
$ |
148,140 |
|
|
Restricted cash |
|
3,632 |
|
|
|
12,924 |
|
|
Total cash, cash equivalents and restricted cash presented in the Consolidated Statements of Cash Flows |
$ |
121,860 |
|
|
$ |
161,064 |
|
See “Note 2 – Summary of Significant Accounting Policies” and “Note 11- Recent Accounting Pronouncements” for a description of restricted cash and cash equivalents.
See notes to consolidated financial statements.
8
CONSOLIDATED SCHEDULE OF INVESTMENTS
March 31, 2018
(unaudited)
(dollars in thousands)
|
Portfolio Company |
|
Sub-Industry |
|
Type of Investment(1) |
|
Maturity Date |
|
Interest Rate and Floor(2) |
|
Principal Amount |
|
|
Cost(3) |
|
|
Value(4) |
|
|||
|
Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Biotechnology Tools |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Exicure, Inc. (12) |
|
Biotechnology Tools |
|
Senior Secured |
|
September 2019 |
|
Interest rate PRIME + 6.45% or Floor rate of 9.95%, 3.85% Exit Fee |
|
$ |
4,999 |
|
|
$ |
5,135 |
|
|
$ |
5,151 |
|
|
Subtotal: 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
5,135 |
|
|
|
5,151 |
|
||
|
Subtotal: Biotechnology Tools (0.62%)* |
|
|
|
|
|
|
|
|
|
|
|
|
5,135 |
|
|
|
5,151 |
|
||
|
Communications & Networking |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
OpenPeak, Inc. (8) |
|
Communications & Networking |
|
Senior Secured |
|
April 2018 |
|
Interest rate PRIME + 8.75% or Floor rate of 12.00% |
|
$ |
11,464 |
|
|
|
8,228 |
|
|
|
— |
|
|
Subtotal: Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
8,228 |
|
|
|
— |
|
||
|
Subtotal: Communications & Networking (0.00%)* |
|
|
|
|
|
|
|
|
|
|
|
|
8,228 |
|
|
|
— |
|
||
|
Consumer & Business Products |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Gadget Guard (p.k.a. Antenna79) (15) |
|
Consumer & Business Products |
|
Senior Secured |
|
December 2018 |
|
Interest rate PRIME + 6.00% or Floor rate of 9.50% |
|
$ |
1,000 |
|
|
|
1,000 |
|
|
|
1,000 |
|
|
Subtotal: Under 1 Year Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
1,000 |
|
|
|
1,000 |
|
||
|
1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Gadget Guard (p.k.a. Antenna79) (15) |
|
Consumer & Business Products |
|
Senior Secured |
|
December 2019 |
|
Interest rate PRIME + 7.45% or Floor rate of 10.95%, 2.95% Exit Fee |
|
$ |
18,043 |
|
|
|
18,245 |
|
|
|
18,133 |
|
|
Subtotal: 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
18,245 |
|
|
|
18,133 |
|
||
|
Subtotal: Consumer & Business Products (2.31%)* |
|
|
|
|
|
|
|
|
|
|
|
|
19,245 |
|
|
|
19,133 |
|
||
|
Diversified Financial Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Gibraltar Business Capital, LLC (7) |
|
Diversified Financial Services |
|
Unsecured |
|
March 2023 |
|
Interest rate FIXED 14.50% |
|
$ |
10,000 |
|
|
|
9,802 |
|
|
|
9,802 |
|
|
Subtotal: 1-5 Years Maturity |
|
|
|
|
|
|
|
|
|
|
|
|
9,802 |
|
|
|
9,802 |
|
||
|
Subtotal: Diversified Financial Services (1.18%)* |
|
|
|
|
|
|
|
|
|
|
|
|
9,802 |
|
|
|
9,802 |
|
||
|
Drug Delivery |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||